

Elliot Turner Returns
May 9, 2024
Elliot Turner, Managing Partner and CIO of RGIA Investment Advisors, discusses learnings from 2021 onwards, specific stock ideas like Fevertree, thoughts on portfolio management, incentives in finance papers, a great NVDA story, life sciences similarities to tech, interesting forces in biotech, costs of failure as opportunity, and more.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10
Introduction
00:00 • 2min
Navigating Market Challenges and Resilience in Investing
01:57 • 18min
Reflections on Company Resilience and Market Trends
20:04 • 2min
Analyzing a London Listed Beverage Company's Performance and Pricing Strategy
21:50 • 24min
Exploring Resiliency in Small Cap Investments
45:44 • 3min
Investment Journey with Nvidia and Lessons Learned
48:59 • 6min
Insights into the Evolution of Life Sciences and Investments
55:00 • 25min
Navigating Challenges in Biotech and Personal Reflections
01:20:04 • 17min
Exploring Business Quality through Antitrust Cases and Government Resources
01:37:01 • 2min
Insights on Congressional Testimonies and Truth-Seeking Dynamics
01:38:35 • 2min